Abstract
Age-related macular degeneration (AMD) is the leading cause of blinding diseases. The “dry” form of AMD is the most common form of AMD. In contrast to the treatable neovascular (wet) AMD, no effective treatment is available for dry AMD. In this review, we summarize the animal models and therapeutic strategies for dry AMD. The novel candidates as potential treatment targets and the potential effectiveness of nanoceria as a treatment of dry AMD are also discussed.
Author supplied keywords
Cite
CITATION STYLE
Cai, X., & McGinnis, J. F. (2016). Nanoceria: A potential therapeutic for dry AMD. In Advances in Experimental Medicine and Biology (Vol. 854, pp. 111–118). Springer New York LLC. https://doi.org/10.1007/978-3-319-17121-0_16
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
